[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

RU2016130803A - Композиция, содержащая сахарат железа и высококонцентрированную микроинкапсулированную дц-пнжк, с уменьшенным посторонним привкусом - Google Patents

Композиция, содержащая сахарат железа и высококонцентрированную микроинкапсулированную дц-пнжк, с уменьшенным посторонним привкусом Download PDF

Info

Publication number
RU2016130803A
RU2016130803A RU2016130803A RU2016130803A RU2016130803A RU 2016130803 A RU2016130803 A RU 2016130803A RU 2016130803 A RU2016130803 A RU 2016130803A RU 2016130803 A RU2016130803 A RU 2016130803A RU 2016130803 A RU2016130803 A RU 2016130803A
Authority
RU
Russia
Prior art keywords
composition
pufa
iron
composition according
microencapsulated
Prior art date
Application number
RU2016130803A
Other languages
English (en)
Other versions
RU2016130803A3 (ru
RU2666190C2 (ru
Inventor
Элоди СУССАН
Рафаэль БЕРРОКАЛЬ
Матье БЕДАРД
Марсель БРАУН
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of RU2016130803A publication Critical patent/RU2016130803A/ru
Publication of RU2016130803A3 publication Critical patent/RU2016130803A3/ru
Application granted granted Critical
Publication of RU2666190C2 publication Critical patent/RU2666190C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
    • A23D9/04—Working-up
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/06—Preservation of finished products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Claims (17)

1. Композиция, обогащенная сахаратом железа и высококонцентрированной микроинкапсулированной длинноцепочечной полиненасыщенной жирной кислотой (ДЦ-ПНЖК).
2. Композиция по п. 1, в которой ДЦ-ПНЖК присутствует в количестве от приблизительно 0,02 до 10 мас. % композиции.
3. Композиция по п. 1, в которой ДЦ-ПНЖК является микроинкапсулированной в стеклообразной матрице из молочных белков и глюкозы, причем упомянутая ДЦ-ПНЖК предпочтительно получена из рыбьего жира или водорослевого масла.
4. Композиция по п. 1, в которой сахарат железа обеспечивает количество железа от приблизительно 0,0001% до приблизительно 1 мас. % композиции.
5. Композиция по п. 1, в которой сахарат железа является микроинкапсулированным, предпочтительно в альгинатной матрице.
6. Композиция по п. 1, которая содержит по меньшей мере один антиоксидант, представляющий собой акцептор радикалов, предпочтительно токоферол (витамин Е).
7. Композиция по п. 1, которая содержит нечувствительный к окислению жир, предпочтительно насыщенный или мононенасыщенный жир, причем наиболее предпочтительно композиция содержит среднецепочечные триглицериды.
8. Композиция по п. 1, которая представляет собой пищевую матрицу, напиток или биологически активную добавку к пище (БАД к пище).
9. Композиция по п. 8, в которой упомянутый пищевой продукт представляет собой питательную композицию, предпочтительно для питания младенцев, детей, матерей или для оздоровительного питания.
10. Композиция по п. 1, которая представляет собой фармацевтическую композицию и/или нутрицевтический продукт.
11. Композиция по п. 1 для применения в профилактике, облегчении или лечении неправильного питания, метаболических заболеваний, нейродегенеративных заболеваний, предпочтительно в качестве питательной добавки.
12. Композиция по п. 1 для применения в обеспечении развития нервной системы и/или сетчатки, в стимуляции и/или улучшении умственной деятельности, поведенческой и зрительной функций младенца или ребенка, для усиления иммунитета, включая развитие микрофлоры кишечника, и/или для уменьшения риска развития избыточного веса, ожирения и резистентности к инсулину.
13. Способ предотвращения или уменьшения окисления ДЦ-ПНЖК в композиции,
содержащей ДЦ-ПНЖК и железо, который включает добавление ДЦ-ПНЖК в композицию в микроинкапсулированной форме и добавление железа в виде сахарата железа, причем предпочтительно ДЦ-ПНЖК микроинкапсулирована в стеклообразной матрице из молочных белков и глюкозы.
14. Способ предотвращения или уменьшения постороннего привкуса ДЦ-ПНЖК в композиции, содержащей ДЦ-ПНЖК и железо, который включает добавление ДЦ-ПНЖК в композицию в микроинкапсулированной форме и добавление железа в виде сахарата железа, причем предпочтительно ДЦ-ПНЖК микроинкапсулирована в стеклообразной матрице из молочных белков и глюкозы.
15. Способ по п. 14, в котором полученная композиция является такой, как определено в соответствии с любым из пп. 1-10.
16. Способ получения композиции по любому из пп. 1-10, который включает стадию смешивания или сухого перемешивания ингредиентов, как определено в соответствии с любым из пп. 1-10.
RU2016130803A 2013-12-27 2014-12-19 Композиция, содержащая сахарат железа и высококонцентрированную микроинкапсулированную дц-пнжк, с уменьшенным посторонним привкусом RU2666190C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13199681 2013-12-27
EP13199681.1 2013-12-27
PCT/EP2014/078909 WO2015097113A1 (en) 2013-12-27 2014-12-19 Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste

Publications (3)

Publication Number Publication Date
RU2016130803A true RU2016130803A (ru) 2018-02-01
RU2016130803A3 RU2016130803A3 (ru) 2018-07-03
RU2666190C2 RU2666190C2 (ru) 2018-09-06

Family

ID=49918477

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016130803A RU2666190C2 (ru) 2013-12-27 2014-12-19 Композиция, содержащая сахарат железа и высококонцентрированную микроинкапсулированную дц-пнжк, с уменьшенным посторонним привкусом

Country Status (10)

Country Link
US (1) US20160310596A1 (ru)
EP (1) EP3086654A1 (ru)
JP (1) JP2017503790A (ru)
CN (1) CN105828642A (ru)
AU (1) AU2014372631B2 (ru)
CA (1) CA2931222A1 (ru)
MX (1) MX2016008287A (ru)
PH (1) PH12016501111A1 (ru)
RU (1) RU2666190C2 (ru)
WO (1) WO2015097113A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6974460B2 (ja) * 2016-12-15 2021-12-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 鉄−カゼイン錯体及び酸化感受性化合物を含む粉末形態の組成物
US20210093578A1 (en) * 2017-04-27 2021-04-01 Clover Corporation Limited Encapsulated nutritional and pharmaceutical compositions
US20210338719A1 (en) 2017-12-28 2021-11-04 Societe Des Produits Nestle S.A. Composition comprising ferrous sulphate monohydrate and long chain polyunsaturated fatty acids
WO2024115306A1 (en) * 2022-11-28 2024-06-06 Frieslandcampina Nederland B.V. Supplemented rtd milk product and method for producing the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5601760A (en) * 1994-09-01 1997-02-11 The Regents Of The University Of California, A California Corporation Milk derived whey protein-based microencapsulating agents and a method of use
DE69623326T2 (de) * 1995-10-27 2003-05-15 The Procter & Gamble Company, Cincinnati Farbestabile mit eisen, zink und vitaminen angereicherte trockene getränkgemischen
DE69739474D1 (de) * 1997-04-29 2009-08-06 Procter & Gamble Farbstabile mit eisen angereicherte trockene getränkemischungen,trinkfertige getränke und andere nahrungsmittel als getränke die gegebenenfalls zink enthalten
CA2230801A1 (en) * 1998-02-27 1999-08-27 Stanley H. Zlotkin Composition comprising micro-encapsulated iron
PH12001000675B1 (en) * 2000-04-04 2009-09-22 Australian Food Ind Sci Ct Encapsulation of food ingredients
CN1170547C (zh) * 2000-09-29 2004-10-13 国家海洋药物工程技术研究中心 无腥鱼油复合微胶囊及其制备方法
US20100015291A1 (en) * 2006-03-21 2010-01-21 Akzo Nobel N.V. Double-fortified salt and preparation process therefor
TW200820913A (en) * 2006-08-25 2008-05-16 Martek Biosciences Corp Food fortification with polyunsaturated fatty acids
RU2007129979A (ru) * 2007-08-06 2009-02-20 Федеральное государственное образовательное учреждение высшего профессионального образовани Кубанский государственный аграрный университет (RU) Железосодержащее средство для профилактики и лечения анемии
EP2174657A1 (en) * 2008-10-08 2010-04-14 AB-Biotics Producciones Industriales De Microbiotas, S.L. Iron source product in the form of capsules and process for their prepartion
CN104522318B (zh) * 2014-12-22 2017-12-05 新奥（厦门）农牧发展有限公司 一种提高富集ω3肉蛋奶的微胶囊脂肪粉及其制备方法

Also Published As

Publication number Publication date
RU2016130803A3 (ru) 2018-07-03
CA2931222A1 (en) 2015-07-02
JP2017503790A (ja) 2017-02-02
WO2015097113A1 (en) 2015-07-02
AU2014372631B2 (en) 2017-12-14
RU2666190C2 (ru) 2018-09-06
PH12016501111A1 (en) 2016-08-15
US20160310596A1 (en) 2016-10-27
MX2016008287A (es) 2016-09-08
AU2014372631A1 (en) 2016-05-26
CN105828642A (zh) 2016-08-03
EP3086654A1 (en) 2016-11-02

Similar Documents

Publication Publication Date Title
CN102422907B (zh) 一种健脑益智调和油
CN101720822A (zh) 一种脂肪酸组分平衡并含有活性成分的中老年型营养调和油
PH12017550006A1 (en) Optimized nutrient fatty acid composition
CN101810226A (zh) 一种脂肪酸组分平衡并含有多种活性成分的儿童型营养调和油
CA2793071A1 (en) Biologically active food supplement
CN107136511A (zh) 一种促进脑神经发育的牡丹籽油组合物、牡丹籽油软胶囊及其制备方法
RU2016130803A (ru) Композиция, содержащая сахарат железа и высококонцентрированную микроинкапсулированную дц-пнжк, с уменьшенным посторонним привкусом
CN106720460A (zh) 食用油
Kadir Nutritional needs of fish to prevent stunting in early childhood
TWI440458B (zh) Containing sesamin and arachidonic acid
CN104543348A (zh) 一种低胆固醇、富胡萝卜素、富ala鸡蛋的生产方法
CN103461542B (zh) 一种直接服用的月子油
CN103766909A (zh) 一种富含欧米伽3复配食品补充剂的新型食品
CN105580983A (zh) 一种低胆固醇、富epa鸡蛋的生产方法
CN104543426A (zh) 一种低胆固醇、富维生素e、富ala鸡蛋的生产方法
CN104430144A (zh) 一种低胆固醇、富锌、富dha鸡蛋的生产方法
CN102552324A (zh) 一种新天然阿胶制备工艺
WO2009017343A2 (en) Functional feed additive
CN104739860A (zh) 一种α-亚麻酸DHA胶囊
Chinasa Nutritional health benefit of coconut (Cocos nucifera) water
CN104509712A (zh) 一种低胆固醇、富维生素e、富epa鸡蛋的生产方法
CN108064971A (zh) 一种健脑的鱼油保健食品
CN104509487A (zh) 一种低胆固醇、富锌、富epa鸡蛋的生产方法
CN104305176A (zh) 一种含有杜仲籽油的保健组合物
CN104642567A (zh) 一种添加海豹油的营养调和油

Legal Events

Date Code Title Description
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20190916

MM4A The patent is invalid due to non-payment of fees

Effective date: 20191220